Robert Grossman, PhD
Precision medicine is an emerging field that looks at how a person’s unique genetic makeup can help determine what treatment might work best for that individual. Although many research studies have shown that precision medicine can lead to better health for some patients, very few of these research studies have looked at precision medicine specifically for African Americans.
The African American Cardiovascular Pharmacogenomics Consortium or ACCOuNT is a group of doctors, researchers, community leaders, and patients whose goal is to ensure that all people benefit fully from precision medicine.
THREE MAIN GOALS
DISCOVERY
Search for genetic variations in African Americans that may affect how a person responds to a medication.
TRANSLATION
Develop recommendations based on genetic variation that doctors can use when prescribing medications to patients.
DISSEMINATION
Share information about precision medicine and pharmacogenomic research with patients and communities.
LEADERSHIP
Minoli Perera, PharmD, PhD
Principal Investigator
David Meltzer, MD, PhDPrincipal Investigator
Doriane Miller, MD
Core Lead
IN THE NEWS
